Drug composition for treating nasopharyngeal cancers

Abstract

The invention provides a drug composition for treating nasopharyngeal cancers. The drug composition includes cis-platinum and at least one of a compound 1, pharmaceutically acceptable salts of the compound 1, a compound 2, pharmaceutically acceptable salts of the compound 2, compound 3 and pharmaceutically acceptable salts of the compound 3, wherein structures of the compound 1, the compound 2 andthe compound 3 are shown in the description; and the total mass of the drug composition is 100%, and the mass percentage content of the cis-platinum is 9-90%. 本发明提供了一种治疗鼻咽癌的药物组合物，包括顺铂以及如下结构所示的化合物1、化合物1药学上可接受的盐、化合物2、化合物2药学上可接受的盐、以及化合物3、化合物3药学上可接受的盐中的至少一种：且以所述药物组合物的总质量为100％计，所述顺铂的质量百分含量为9‑90％。